<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vedomostiregmed</journal-id><journal-title-group><journal-title xml:lang="ru">Регуляторные исследования и экспертиза лекарственных средств</journal-title><trans-title-group xml:lang="en"><trans-title>Regulatory Research and Medicine Evaluation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">3034-3062</issn><issn pub-type="epub">3034-3453</issn><publisher><publisher-name>Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">vedomostiregmed-54</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ГОСУДАРСТВЕННАЯ ФАРМАКОПЕЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>STATE PHARMACOPOEIA</subject></subj-group></article-categories><title-group><article-title>Актуальные вопросы оценки качества препаратов в лекарственной форме «таблетки»</article-title><trans-title-group xml:lang="en"><trans-title>Relevant issues of testing quality of drugs in the form of tablets</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ковалева</surname><given-names>Елена Леонардовна</given-names></name><name name-style="western" xml:lang="en"><surname>Kovaleva</surname><given-names>E. L.</given-names></name></name-alternatives><email xlink:type="simple">Kovaleva@expmed.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Матвеева</surname><given-names>Оксана Анатольевна</given-names></name><name name-style="western" xml:lang="en"><surname>Matveeva</surname><given-names>O. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колганова</surname><given-names>Екатерина Евгеньевна</given-names></name><name name-style="western" xml:lang="en"><surname>Kolganova</surname><given-names>E. E.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Миронова</surname><given-names>Мария Михайловна</given-names></name><name name-style="western" xml:lang="en"><surname>Mironova</surname><given-names>M. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное учреждение «Научный центр экспертизы средств медицинского применения» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>13</day><month>02</month><year>2018</year></pub-date><volume>0</volume><issue>3</issue><fpage>53</fpage><lpage>59</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ковалева Е.Л., Матвеева О.А., Колганова Е.Е., Миронова М.М., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Ковалева Е.Л., Матвеева О.А., Колганова Е.Е., Миронова М.М.</copyright-holder><copyright-holder xml:lang="en">Kovaleva E.L., Matveeva O.A., Kolganova E.E., Mironova M.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.vedomostincesmp.ru/jour/article/view/54">https://www.vedomostincesmp.ru/jour/article/view/54</self-uri><abstract><p>Рассмотрены основные направления совершенствования подходов к оценке качества препаратов в лекарственной форме «таблетки» по показателям «Подлинность», «Растворение», «Распадаемость», «Родственные примеси», «Остаточные органические растворители», «Количественное определение». Проведен сравнительный анализ требований ведущих зарубежных фармакопей, материалов ВОЗ и национальных требований по стандартизации таблеток. Обсуждены вопросы, связанные с классификацией препаратов, используемой терминологией в наименованиях выделяемых групп таблеток, различием в выборе методов анализа, подходах к оценке показателей, использовании стандартных образцов. Проведенный анализ позволяет определить национальные требования к качеству таблеток, что особенно важно в связи с предстоящей работой по подготовке фармакопейных статей на лекарственные препараты для Государственной фармакопеи РФ.</p></abstract><trans-abstract xml:lang="en"><p>The article reviews major ways of streamlining approaches to testing the following quality parameters of drugs presented in the dosage form oftablets: “Identification”, “Dissolution”, “Disintegration”, “Related impurities”, “Residual organic solvents”, “Assay”. The article describes results of a comparative analysis of requirements laid down in the leading world pharmacopoeias, WHO documents and national requirements for tablets standardization. The analysis covers such issues as classification of drugs, terms used to describe various tablet groups, differences in the choice of test methods, as well as in approaches to assessment of parameters and use of reference standards. The analysis makes it possible to define national requirements for tablets quality, which is particularly important in view of the future work on the development of pharmacopoeial monographs on drugs for the State Pharmacopoeia of the Russian Federation.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>лекарственные препараты</kwd><kwd>таблетки</kwd><kwd>качество</kwd><kwd>примеси</kwd><kwd>растворение</kwd><kwd>распадаемость</kwd><kwd>органические растворители</kwd><kwd>drugs</kwd><kwd>tablets</kwd><kwd>quality</kwd><kwd>impurities</kwd><kwd>dissolution</kwd><kwd>disintegration</kwd><kwd>organic solvents</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Проект Приказа Минздрава России «Об утверждении перечня наименований лекарственных форм». Available from: http://regulation.gov.ru/project/23007.</mixed-citation><mixed-citation xml:lang="en">Draft Order of the Russian Ministry of Health «On approving the list of types of dosage forms». Available from: http://regulation.gov.ru/project/23007 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">European Pharmacopoeia 8th ed., Supplement 8.2. European Directorate for the Quality of Medicines. Available from: http://online.edqm.eu/entry.htm.</mixed-citation><mixed-citation xml:lang="en">European Pharmacopoeia 8th ed., Supplement 8.2. European Directorate for the Quality of Medicines. Available from: http://online.edqm.eu/entry.htm.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Государственная Фармакопея СССР. 11-е изд. Вып. 2. М.: Медицина; 1989.</mixed-citation><mixed-citation xml:lang="en">The State Pharmacopoeia of USSR. 11th ed. V. 2. Moscow: Meditsina; 1989 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Государственная Фармакопея РФ. 12-е изд. Часть 1. М.: Научный Центр экспертизы средств медицинского применения; 2007.</mixed-citation><mixed-citation xml:lang="en">The State Pharmacopoeia of Russian Federation. 12th ed. V. 1. Moscow: Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation; 2007 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Good pharmacopoeial practices. Working document QAS/13.526/Rev.6 July 2015. Document for comments. Available from: http://www.who.int/medicines/areas/quality_safety/quality_assurance/GPhP-QAS13-526-Rev6-meeting_24072015.pdf.</mixed-citation><mixed-citation xml:lang="en">Good pharmacopoeial practices. Working document QAS/13.526/Rev.6 July 2015.  Document for comments. Available from: http://www.who.int/medicines/areas/quality_safety/quality_assurance/GPhP-QAS13-526- Rev6-meeting_24072015.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">ОСТ 91500.05.001-00 «Стандарты качества лекарственных средств. Основные положения» (утв. приказом Минздрава РФ от 1 ноября 2001 г. N 388, утратил силу с 29 мая 2015 года на основании приказа Минздрава России от 24 апреля 2015 года N 209н).</mixed-citation><mixed-citation xml:lang="en">OST 91500.05.001-00 «Standards for Quality of Medicines. Basic provisions» (approved by the order of the Ministry of Health dated November 1, 2001 № 388, repealed from 29 May 2015 on the basis of Order Ministry of Health of Russia on April 24th, 2015 № 209n) (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Руководство по экспертизе лекарственных средств, Том II. М.: Гриф и К, 2013.</mixed-citation><mixed-citation xml:lang="en">Mironov AN, ed. Guideline for expertise of drugs. V. II. Moscow: Grif i K; 2013 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Общая Фармакопейная Статья «Растворение» ОФС 42-0003-04 (утверждено Федеральной службой по надзору в сфере здравоохранения и социального развития Приказ от 13.09.2004 № 145-пР/04).</mixed-citation><mixed-citation xml:lang="en">General Pharmacopeial article «Dissolution» OFS 42-0003-04 (approved by the Federal Service on Surveillance in Healthcare and Social Development Order from 13.09.2004 № 145-PR/04) (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Приказ Минздрава России от 24 апреля 2015 года N 209н О признании утратившим силу приказа Министерства здравоохранения Российской Федерации от 1 ноября 2001 года N 388 «О государственных стандартах качества лекарственных средств».</mixed-citation><mixed-citation xml:lang="en">Order of the Russian Ministry of Health on April 24, 2015 № 209n Invalidity of the order of the Ministry of Health of the Russian Federation dated November 1, 2001 № 388 «About the state quality standards of drugs» (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Список общих фармакопейных статей и фармакопейных статей. Available from: http://www.rosminzdrav.ru/ministry/61/11/materialy-po-deyatelnosti-deparatamenta/stranitsa-856/spisok-obschih-farmakopeynyh-statey.</mixed-citation><mixed-citation xml:lang="en">List of general pharmacopoeial articles and pharmacopoeial articles. Available from: http://www.rosminzdrav.ru/ministry/61/11/materialy-po-deyatelnosti-deparatamenta/stranitsa-856/spisok-obschih-farmakopeynyh-statey (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">British Pharmacopoeia 2015th ed. The British Pharmacopoeia Commission. Available from: https://www.pharmacopoeia.com.</mixed-citation><mixed-citation xml:lang="en">British Pharmacopoeia 2015th ed. The British Pharmacopoeia Commission. Available  from: https://www.pharmacopoeia.com.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">United States Pharmacopeia, 38th edition Available from: http://www.uspnf.com/uspnf.</mixed-citation><mixed-citation xml:lang="en">United States Pharmacopeia, 38th edition Available from: http://www.uspnf.com/uspnf.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances Q6A ICH harmonized tripartite guideline. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q6A/Step4/Q6Astep4.pdf.</mixed-citation><mixed-citation xml:lang="en">Specifications: Test Procedures and Acceptance Criteria for New Drug Sub-stances and New Drug Products: Chemical Substances Q6A ICH harmonized tripartite guideline.  Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q6A/Step4/Q6Astep4.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">ОСТ 42-506-96 «Порядок разработки, согласования и утверждения нормативной документации на лекарственные средства и лекарственное растительное сырье».</mixed-citation><mixed-citation xml:lang="en">OST 42-506-96 «Procedure for the development, coordination and approval of regulatory documents on medicines and medicinal herbs» (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Impurities in New Drug Products Q3B(R2) ICH harmonized tripartite guideline. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q3B_R2/Step4/Q3B_R2__Guideline.pdf.</mixed-citation><mixed-citation xml:lang="en">Impurities in New Drug Products Q3B(R2) ICH harmonized tripartite guideline. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q3B_R2/Step4/Q3B_R2__Guideline.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Impurities in Drug Substances and Drug Products (&lt;1086&gt;). Available from: http://www.usp.org/sites/default/files/usp_pdf/EN/chapter_1086.pdf.</mixed-citation><mixed-citation xml:lang="en">Impurities in Drug Substances and Drug Products (&lt;1086&gt;). Available from: http://www.usp.org/sites/default/files/usp_pdf/EN/chapter_1086.pdf.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
